63 related articles for article (PubMed ID: 38662286)
1. Comprehensive molecular characterization of long-term glioblastoma survivors.
Xu H; Chen X; Sun Y; Hu X; Zhang X; Wang Y; Tang Q; Zhu Q; Song K; Chen H; Sheng X; Yao Y; Zhuang D; Chen L; Mao Y; Qin Z
Cancer Lett; 2024 May; 593():216938. PubMed ID: 38734160
[TBL] [Abstract][Full Text] [Related]
2. Predictive Model to Identify the Long Time Survivor in Patients with Glioblastoma: A Cohort Study Integrating Machine Learning Algorithms.
Yang XL; Zeng Z; Wang C; Sheng YL; Wang GY; Zhang FQ; Lian X
J Mol Neurosci; 2024 Apr; 74(2):48. PubMed ID: 38662286
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomic analysis of survival outliers in glioblastoma.
Peng S; Dhruv H; Armstrong B; Salhia B; Legendre C; Kiefer J; Parks J; Virk S; Sloan AE; Ostrom QT; Barnholtz-Sloan JS; Tran NL; Berens ME
Neuro Oncol; 2017 Jun; 19(6):833-844. PubMed ID: 27932423
[TBL] [Abstract][Full Text] [Related]
4. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
5. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
6. Molecular features of glioblastomas in long-term survivors compared to short-term survivors-a matched-pair analysis.
Sommerlath VN; Buergy D; Etminan N; Brehmer S; Reuss D; Sarria GR; Guiot MC; Hänggi D; Wenz F; Petrecca K; Giordano FA
Radiat Oncol; 2022 Jan; 17(1):15. PubMed ID: 35073955
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
Michaelsen SR; Urup T; Olsen LR; Broholm H; Lassen U; Poulsen HS
J Neurooncol; 2018 May; 137(3):533-542. PubMed ID: 29305787
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).
Hertler C; Felsberg J; Gramatzki D; Le Rhun E; Clarke J; Soffietti R; Wick W; Chinot O; Ducray F; Roth P; McDonald K; Hau P; Hottinger AF; Reijneveld J; Schnell O; Marosi C; Glantz M; Darlix A; Lombardi G; Krex D; Glas M; Reardon DA; van den Bent M; Lefranc F; Herrlinger U; Razis E; Carpentier AF; Phillips S; Rudà R; Wick A; Tabouret E; Meyronet D; Maurage CA; Rushing E; Rapkins R; Bumes E; Hegi M; Weyerbrock A; Aregawi D; Gonzalez-Gomez C; Pellerino A; Klein M; Preusser M; Bendszus M; Golfinopoulos V; von Deimling A; Gorlia T; Wen PY; Reifenberger G; Weller M
Eur J Cancer; 2023 Aug; 189():112913. PubMed ID: 37277265
[TBL] [Abstract][Full Text] [Related]
9. Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients' survival.
Moreno DA; da Silva LS; Gomes I; Leal LF; Berardinelli GN; Gonçalves GM; Pereira CA; Santana IVV; Matsushita MM; Bhat K; Lawler S; Reis RM
Ther Adv Med Oncol; 2022; 14():17588359221127678. PubMed ID: 36579028
[TBL] [Abstract][Full Text] [Related]
10. Assessment of radiographic and prognostic characteristics of programmed death-ligand 1 expression in high-grade gliomas.
Ohno M; Kitano S; Satomi K; Yoshida A; Miyakita Y; Takahashi M; Yanagisawa S; Tamura Y; Ichimura K; Narita Y
J Neurooncol; 2022 Nov; 160(2):463-472. PubMed ID: 36282354
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma.
Wei ST; Chiang JY; Wang HL; Lei FJ; Huang YC; Wang CC; Cho DY; Hsieh CH
Cancer Sci; 2023 Jan; 114(1):174-186. PubMed ID: 36106406
[TBL] [Abstract][Full Text] [Related]
12. Elevated Hexose-6-Phosphate Dehydrogenase Regulated by OSMR-AS1/hsa-miR-516b-5p Axis Correlates with Poor Prognosis and Dendritic Cells Infiltration of Glioblastoma.
Zhang YB; Zheng SF; Ma LJ; Lin P; Shang-Guan HC; Lin YX; Kang DZ; Yao PS
Brain Sci; 2022 Jul; 12(8):. PubMed ID: 36009075
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic Biomarkers of Glioblastoma Based on Multidatabase Integration and Its Correlation with Immune-Infiltration Cells.
Ding W; Zhou X; Jiang G; Xu W; Long S; Xiao F; Liao Y; Liu J
J Oncol; 2022; 2022():3909030. PubMed ID: 35685428
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
